Table 2.
Clinical Trials | |||||
---|---|---|---|---|---|
Reference | Sample Characteristics at Baseline | Endotoxemia Assessment | Nutritional Assessment | Analysis Design | Results |
Laugerette F. et al., Mol Nutr Food Res, 2014 [46] | 18 healthy subjects (mean age 31 y, all men) | Plasma LPS quantified by LAL | Overfeeding with +70 g of lipids to the usual daily diet with 46.3% from saturated fatty acids during 8 weeks | Controlled trial | Postprandial levels of LPS compared to baseline |
No difference in fasting levels of LPS after overfeeding period compared to baseline | |||||
Breusing N. et al., J Am Coll Nutr, 2017 [50] | 15 healthy subjects (age 20–29 y, all men) | Plasma LPS quantified by LAL | Overfeeding (+50% of the energy requirement) during 1 week, caloric restriction (−50% of the energy requirement, 3.5% fat) during 3 weeks and hyper-caloric refeeding (+50% of the energy requirement) with either low- or high-glycemic index diet during 2 weeks | Randomized crossover study | Fasting levels of LPS after overfeeding period (+30.8% compared to baseline) |
Normalization of fasting levels of LPS levels with the caloric restriction diet | |||||
Fasting levels of LPS after hyper-caloric refeeding period (+24.7% compared to baseline) | |||||
López-Moreno J. et al., J Agric Food Chem, 2017 [48] | 75 subjects with metabolic syndrome (mean age 56 y) | Plasma LPS quantified by LAL | Four diets (High-saturated-fatty acids diet (HSFA, 38% fat with 16% SFA, 12% MUFA and 6% PUFA), High MUFA (HMUFA, 38% fat with 8% SFA, 20% MUFA and 6% PUFA), Low-fat high complex carbohydrate (LFHCC, 28% fat) and LFHCC n-3 supplemented with n-3 PUFA) during 12 weeks | Randomized controlled trial | Postprandial levels of LPS after HSFA diet compared to baseline |
No difference in postprandial LPS levels after HMUFA, LFHCC and LFHCC n-3 diets | |||||
No difference in fasting levels of LPS between all 4 groups of diet after intervention | |||||
López-Moreno J. et al., Exp Gerontol, 2018 [47] | 20 healthy subjects (mean age 67 y, 50% men) | Plasma LPS quantified by LAL | Mediterranean diet enriched in MUFA with virgin olive oil (38% fat) or SFA-rich diet (38% fat) or low-fat high-carbohydrate diet enriched in n-3 PUFA (CHO-PUFA diet, 30% fat) during 3 weeks | Randomized crossover study | Postprandial levels of LPS after CHO-PUFA |
No difference in postprandial levels of LPS after Mediterranean diets enriched in MUFA or SFA | |||||
Fasting levels of LPS after CHO-PUFA diet compared to Mediterranean diets enriched in MUFA or SFA | |||||
Pendyala S. et al., Gastroenterology, 2012 [49] | 8 healthy subjects (mean age 60 y, 38% men) hospitalized for the study | Plasma LPS quantified by a neutrophil priming method | Western-type diet (40% fat with 20.8% from saturated fat, 20% protein and 40% carbohydrates) or Prudent-type diet (20% with 5.8% from saturated fat, 20% protein and 60% carbohydrates) during 1 month | Randomized crossover study | Fasting levels of LPS after Western-type diet (+71% compared to baseline) |
Fasting levels of LPS after prudent-type diet (−38% compared to baseline) | |||||
Observational studies | |||||
Reference | Sample Characteristics at Baseline | Endotoxemia Assessment | Nutritional Assessment | Analysis Design | Results |
Amar J. et al., Am J Clin Nutr, 2008 [51] | 130 subjects below the LPS detection threshold (mean age 55 y), 44 subjects between 9–39 U/mL (mean age 54 y) and 27 subjects under 39 U/mL (mean age 53 y), all healthy men | Plasma LPS quantified by Kinetic-QCL TM test | 3 days of food-record diary | Cross-sectional | Fasting levels of LPS with fat and total energy intake |
Kallio KA. et al., Acta Diabetol, 2015 [52] | 2452 subjects (mean age 52 y) | Serum LPS quantified by LAL | 24 h dietary recall | Cross-sectional | Fasting levels of LPS with total energy intake in lean healthy subjects |
No significant association between fasting levels of LPS and fat intake, and among subjects with obesity, metabolic syndrome, diabetes or coronary heart disease | |||||
Röytiö H. et al., Br J Nutr, 2017 [53] | 88 overweight pregnant women (mean age 30 y) | Serum LPS quantified by LAL | Three groups based on 3 days of food-record diary (low fibre (<25 g/j) and moderate fat intake (25–40%) n = 57, high fibre (>=25 g/j) and moderate fat intake (25–40%) n=18 and low fibre (<25 g/j) and high fat intake (>=40%) n = 13) | Cross-sectional | No significant association between fasting levels of LPS and fat intake |
No difference in fasting levels of LPS levels among the three diet groups | |||||
Ahola AJ. Et al., Sci Rep, 2017 [54] | 668 patients with type 1 diabetes (mean age 45 y, 44% men) | Serum LPS quantified by LAL | Food frequency questionnaire and3 days of food-records diary | Cross-sectional | Fasting levels of LPS with higher adherence score of fish, healthy snack and modern diets |
No difference in fasting levels of LPS levels for sweet, cheese, vegetable or traditional diets | |||||
No difference in fasting levels of LPS levels for energy, macronutrients and fibre intake | |||||
Pastori D. et al., J Am Heart Assoc, 2017 [55] | 704 patients with nonvalvular atrial fibrillation treated by vitamin K antagonists (mean age 74 y, 57% men) | Serum LPS quantified by ELISA | Short food frequency questionnaire | Cross-sectional | Fasting levels of LPS with higher adherence to a Mediterranean diet |
Fasting levels of LPS with higher consumption of fruits and legumes | |||||
No difference in fasting levels of LPS levels for the consumption of olive oil, vegetables, fish, wine, meat and bread |
Abbreviations: AD Alzheimer’s Disease; LPS Lipopolysaccharide; LAL Limulus Amebocyte Lysate; SFA Saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids.